Cellbion셀비온
308430 · KOSDAQ · ₩308430 · 셀비온
₩11,940▲ ₩620 (5.48%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Gross margin | −4.5% | 4.6% | 42.2% |
| Operating margin | −447.2% | −423.9% | −311.7% |
| Net margin | 406.5% | −389.4% | −317.3% |
Growth (year on year)
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Revenue growth | +10.3% | −15.1% | — |
| Operating income growth | −16.4% | −15.5% | — |
| Net income growth | +215.2% | −4.2% | — |
Returns
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Return on equity | 29.6% | −28.9% | −24.6% |
| Return on assets | 14.7% | −21.8% | −21.1% |
Leverage and liquidity
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Liabilities to equity | 130.6% | 54.5% | 16.3% |
| Net debt to equity | −167.7% | −98.5% | −98.1% |
| Current ratio | 3,344.4% | 1,110.0% | 2,957.8% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Cellbion / 셀비온 / 308430 / KRX:308430
Source: KRX statistical information